DNA Vaccines : A New Era in Vaccinology - Proceedings of a New York Academy of Sciences Conference, Arlington, Virginia, April 6-9, 1995

This conference provides an evaluation of current research on the powerful new technology of DNA vaccines. DNA vaccines hold great promise for prevention and immunotherapy of viral and parasitic infections and cancer, particularly those diseases for which development of traditional vaccines has proved difficult. Preclinical studies recently demonstrated the potential for polynucleotides encoding proteins from pathogens to be a novel and effective means of vaccination, generating cellular and antibody responses while avoiding the potential risks of approaches utilising live viruses.